p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Duta Pharma Journal
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Clinicopathologic Characteristics, Pathological Response and Safety Profile of Triple-Negative Breast Cancer (TNBC) Patients: A Retrospective Study in Yogyakarta Rommy; Clara Ritawany Sinaga; Annafiatuzakiah
Duta Pharma Journal Vol. 6 No. 1 (2026): Duta Pharma Journal
Publisher : Universitas Duta Bangsa Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47701/hy4h0v48

Abstract

Background: Triple-negative breast cancer (TNBC) is a uniquely aggressive molecular subtype associated with poor prognosis, high proliferation rates, and significant genomic instability. Objective: This study aimed to determine the clinicopathologic characteristics, pathological response, and safety profile of TNBC patients in a local clinical setting. Method: A retrospective cohort study was conducted on 50 female patients at a private hospital in Yogyakarta (2019–2022). Chemotherapy regimens were categorized into platinum-based (carboplatin and taxane) and non-platinum-based (anthracycline-taxane, capecitabine, or methotrexate) groups. Pathological complete response (pCR) was defined as the total absence of residual invasive carcinoma in both the breast tissue and sampled regional lymph nodes (ypT0/Tis ypN0). Data were extracted from medical records and analyzed using bivariate statistical tests. Results: The mean age was 48.48 years (95% CI: 46.24–50.72), with 76% of patients aged 40-59. Most patients presented with cT2 tumor size (38%) and cN0 nodal status (58%). The mean Ki67 index was 24.96 (95% CI: 19.29–30.63), with 44% of patients exhibiting high proliferation (? 30%). The overall pCR rate was 20% (10/50). The platinum group achieved a higher numerical pCR rate (25%, 6/24) compared to the non-platinum group (15.4%, 4/26), though the difference was not statistically significant (OR = 1.833, 95% CI: 0.448–7.511, p = 0.490). A high Ki67 index (? 30%) was significantly associated with superior pCR achievement (OR = 7.428, 95% CI: 1.365–40.413, p = 0.014). Adverse drug reactions (ADRs) occurred in 66% (33/50) of patients, predominantly chemotherapy-induced nausea and vomiting (22%) and neurological disorders (20%). Conclusion: High Ki67 expression was associated with therapeutic response in this cohort. No statistically significant difference in pCR or total ADR incidence was observed between regimens in this sample. The study is limited by its single-center design and small sample size (n=50)
Hubungan Kepatuhan Penggunaan Obat Antihipertensi Dengan Jarak Tempuh ke Puskesmas Sekolaq Darat Kabupaten Kutai Barat Annafiatuzakiah; Clara Ritawany Sinaga; Esty Elvinda; Hana Oktaviya
Duta Pharma Journal Vol. 5 No. 1 (2025): Duta Pharma Journal
Publisher : Universitas Duta Bangsa Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47701/djp.v5i1.4910

Abstract

Bagi pasien hipertensi kepatuhan dalam menjalani pengobatan dapat mempengaruhi kesembuhan pasien. Faktor yang mempengaruhi kepatuhan pasien hipertensi adalah jarak rumah dengan fasilitas kesehatan seperti Puskesmas, Rumah Sakit, dan fasilitas lainnya. Penelitian ini bertujuan untuk mengetahui hubungan kepatuhan penggunaan obat pasien hipertensi dengan jarak tempuh ke Puskesmas Sekolaq Darat Kabupaten Kutai Barat. Penelitian ini dilaksanakan pada periode Mei-Juni 2023 dengan metode observasional analitik dengan pendekatan cross sectional. Pengambilan sampel menggunakan metode Non- probability sampling dengan teknik Purposive Sampling, alat ukur yang digunakan adalah kuesioner Medication Adherence Report Scale (MARS-5) dan di analisis menggunakan metode univariat dan bivariat dengan skala likert dan data di analisis menggunakan SPSS 26.0 dengan menggunakan uji Chi-Square. Sampel yang diteliti sebanyak 80 responden yang terdiri dari pasien hipertensi yang tercatat di Puskesmas Sekolaq Darat. Penelitian menunjukan kategori kepatuhan tinggi sebanyak 35%, kategori kepatuhan sedang sebanyak 65%, dan kategori kepatuhan rendah sebanyak 0%. Hasil uji bivariat didapatkan bahwa nilai antara kepatuhan penggunaan obat hipertensi tidak berhubungan signifikan dengan jarak tempuh ke Puskesmas (p = 0,940) >0,05. Hal ini menunjukkan bahwa faktor jarak bukan merupakan determinan utama kepatuhan terapi pada pasien hipertensi di wilayah tersebut. Dengan demikian, upaya peningkatan kepatuhan pasien sebaiknya difokuskan pada faktor lain seperti edukasi pasien, motivasi internal, dukungan keluarga, serta pemantauan terapi secara berkesinambungan oleh tenaga kesehatan.